Camouflage and interception: how pathogens evade detection by intracellular nucleic acid sensors

Immunology

Volumn 156, Issue 3, 2019, Pages 217-227

  Unterholzner, Leonie ^a   Almine, Jessica F ^a  

^a LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

DNA sensing; immune evasion; interferon; intracellular pathogens; retinoic acid inducible gene I like receptors; viruses

Indexed keywords

ADAPTOR PROTEIN; CYTOKINE; DINUCLEOTIDE; DNA; HOST FACTOR; INTERFERON; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; NUCLEIC ACID; PATHOGEN ASSOCIATED MOLECULAR PATTERN; RETINOIC ACID INDUCIBLE PROTEIN I; RNA; STING PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VIRUS DNA; VIRUS RNA;

BACTERIAL STRAIN; BACTERIUM; CYTOSOL; HOST PATHOGEN INTERACTION; IMMEDIATE EARLY GENE; IMMUNE EVASION; IMMUNOMODULATION; INFECTIOUS AGENT; INNATE IMMUNITY; INTRACELLULAR MEMBRANE; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTOZOON; QUORUM SENSING; REVIEW; ANIMAL; CYTOPLASM; HUMAN; IMMUNOLOGY; SIGNAL TRANSDUCTION; VIRUS;

ANIMALS; BACTERIA; CYTOPLASM; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INTERFERON TYPE I; NUCLEIC ACIDS; SIGNAL TRANSDUCTION; VIRUSES;

EID: 85058707309     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.13030     Document Type: Review

References (162)

1. Blander JM, Sander LE. Beyond pattern recognition: five immune checkpoints for scaling the microbial threat. Nat Rev Immunol 2012; 12:215–25.
2. Beachboard DC, Horner SM. Innate immune evasion strategies of DNA and RNA viruses. Curr Opin Microbiol 2016; 32:113–9.
3. Dos-Santos ALA, Carvalho-Kelly LF, Dick CF, Meyer-Fernandes JR. Innate immunomodulation to trypanosomatid parasite infections. Exp Parasitol 2016; 167:67–75.
4. Reddick LE, Alto NM. Bacteria fighting back: how pathogens target and subvert the host innate immune system. Mol Cell 2014; 54:321–8.
5. Schlee M, Hartmann G. Discriminating self from non-self in nucleic acid sensing. Nat Rev Immunol 2016; 16:566–80.
6. Lässig C, Hopfner K-P. Discrimination of cytosolic self and non-self RNA by RIG-I-like receptors. J Biol Chem 2017; 292:9000–9.
7. Chiang C, Gack MU. Post-translational control of intracellular pathogen sensing pathways. Trends Immunol 2017; 38:39–52.
8. Hou F, Sun L, Zheng H, Skaug B, Jiang Q-X, Chen ZJ. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011; 146:448–61.
9. Xing J, Zhang A, Minze LJ, Li XC, Zhang Z. TRIM29 negatively regulates the Type I IFN production in response to RNA virus. J Immunol 2018; 201:183–92.
10. Nistal-Villán E, Gack MU, Martínez-Delgado G, Maharaj NP, Inn K-S, Yang H et al. Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-β production. J Biol Chem 2010; 285:20252–61.
11. Xiang W, Zhang Q, Lin X, Wu S, Zhou Y, Meng F et al. PPM1A silences cytosolic RNA sensing and antiviral defense through direct dephosphorylation of MAVS and TBK1. Sci Adv 2016; 2:e1501889.
12. Gack MU, Nistal-Villán E, Inn K-S, García-Sastre A, Jung JU. Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J Virol 2010; 84:3220–9.
13. Saito T, Hirai R, Loo Y-M, Owen D, Johnson CL, Sinha SC et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci USA 2007; 104:582–7.
14. Shi Y, Yuan B, Qi N, Zhu W, Su J, Li X et al. An autoinhibitory mechanism modulates MAVS activity in antiviral innate immune response. Nat Commun 2015; 6:7811.
15. Schlee M. Master sensors of pathogenic RNA – RIG-I like receptors. Immunobiology 2013; 218:1322–35.
16. Pichlmair A, Schulz O, Tan CP, Näslund TI, Liljeström P, Weber F et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 2006; 314:997–1001.
17. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, Bier K et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010; 140:397–408.
18. Goubau D, Schlee M, Deddouche S, Pruijssers AJ, Zillinger T, Goldeck M et al. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates. Nature 2014; 514:372–5.
19. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441:101–5.
20. Pichlmair A, Schulz O, Tan CP, Rehwinkel J, Kato H, Takeuchi O et al. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol 2009; 83:10761–9.
21. Gitlin L, Benoit L, Song C, Cella M, Gilfillan S, Holtzman MJ et al. Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo. PLoS Pathog 2010; 6:e1000734.
22. Feng Q, Hato SV, Langereis MA, Zoll J, Virgen-Slane R, Peisley A et al. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep 2012; 2:1187–96.
23. McCartney SA, Thackray LB, Gitlin L, Gilfillan S, Virgin HW, Virgin Iv HW et al. MDA-5 recognition of a murine norovirus. PLoS Pathog 2008; 4:e1000108.
24. Chhabra P, Ranjan P, Cromeans T, Sambhara S, Vinjé J. Critical role of RIG-I and MDA5 in early and late stages of Tulane virus infection. J Gen Virol 2017; 98:1016–26.
25. Chiang JJ, Sparrer KMJ, van Gent M, Lässig C, Huang T, Osterrieder N et al. Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity. Nat Immunol 2018; 19:53–62.
26. Rasmussen SB, Jensen SB, Nielsen C, Quartin E, Kato H, Chen ZJ et al. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene- like receptors, which synergize to induce type I interferon production. J Gen Virol 2009; 90:74–8.
27. Minamitani T, Iwakiri D, Takada K. Adenovirus virus-associated RNAs induce type I interferon expression through a RIG-I-mediated pathway. J Virol 2011; 85:4035–40.
28. Samanta M, Iwakiri D, Kanda T, Imaizumi T, Takada K. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J 2006; 25:4207–14.
29. Delaloye J, Roger T, Steiner-Tardivel Q-G, Le Roy D, Knaup Reymond M, Akira S et al. Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog 2009; 5:e1000480.
30. Schmolke M, Patel JR, de Castro E, Sanchez-Aparicio MT, Uccellini MB, Miller JC et al. RIG-I detects mRNA of intracellular Salmonella enterica serovar Typhimurium during bacterial infection. MBio 2014; 5:e01006-14.
31. Jehl SP, Nogueira CV, Zhang X, Starnbach MN. IFN-γ inhibits the cytosolic replication of Shigella flexneri via the cytoplasmic RNA sensor RIG-I. PLoS Pathog 2012; 8:e1002809.
32. Hagmann CA, Herzner AM, Abdullah Z, Zillinger T, Jakobs C, Schuberth C et al. RIG-I detects triphosphorylated RNA of Listeria monocytogenes during infection in non-immune cells. PLoS ONE 2013; 8:e62872.
33. Dhir A, Dhir S, Borowski LS, Jimenez L, Teitell M, Rötig A et al. Mitochondrial double-stranded RNA triggers antiviral signalling in humans. Nature 2018; 560:238–42.
34. Malathi K, Dong B, Gale M, Silverman RH. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007; 448:816–9.
35. Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013; 339:786–91.
36. Gao P, Ascano M, Zillinger T, Wang W, Dai P, Serganov AA et al. Structure–function analysis of STING activation by c[G(2′,5′)pA(3″,5″)p] and targeting by antiviral DMXAA. Cell 2013; 154:748–62.
37. Liu S, Cai X, Wu J, Cong Q, Chen X, Li T et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 2015; 347:aaa2630.
38. Dobbs N, Burnaevskiy N, Chen D, Gonugunta VK, Alto NM, Yan N. STING activation by translocation from the ER is associated with infection and autoinflammatory disease. Cell Host Microbe 2015; 18:157–68.
39. Unterholzner L. The interferon response to intracellular DNA: why so many receptors? Immunobiology 2013; 218:1312–21.
40. Almine JF, O'Hare CAJ, Dunphy G, Haga IR, Naik RJ, Atrih A et al. IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes. Nat Commun 2017; 8:14392.
41. Jønsson KL, Laustsen A, Krapp C, Skipper KA, Thavachelvam K, Hotter D et al. IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP. Nat Commun 2017; 8:14391.
42. Orzalli MH, DeLuca NA, Knipe DM. Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci USA 2012; 109:E3008–17.
43. Morrone SR, Wang T, Constantoulakis LM, Hooy RM, Delannoy MJ, Sohn J. Cooperative assembly of IFI16 filaments on dsDNA provides insights into host defense strategy. Proc Natl Acad Sci USA 2014; 111:E62–71.
44. Stratmann SA, Morrone SR, van Oijen AM, Sohn J. The innate immune sensor IFI16 recognizes foreign DNA in the nucleus by scanning along the duplex. Elife 2015; 4:e11721.
45. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009; 458:514–8.
46. Bürckstümmer T, Baumann C, Blüml S, Dixit E, Dürnberger G, Jahn H et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009; 10:266–72.
47. Fernandes-Alnemri T, Yu J-W, Datta P, Wu J, Alnemri ES. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009; 458:509–13.
48. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007; 448:501–5.
49. Ferguson BJ, Mansur DS, Peters NE, Ren H, Smith GL. DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife 2012; 1:e00047.
50. Kim T, Pazhoor S, Bao M, Zhang Z, Hanabuchi S, Facchinetti V et al. Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc Natl Acad Sci USA 2010; 107:15181–6.
51. Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu Y-J. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol 2011; 12:959–65.
52. Kondo T, Kobayashi J, Saitoh T, Maruyama K, Ishii KJ, Barber GN et al. DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc Natl Acad Sci USA 2013; 110:2969–74.
53. Gao D, Wu J, Wu Y-T, Du F, Aroh C, Yan N et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses – supplementary materials. Science 2013; 341:903–6.
54. Li X-D, Wu J, Gao D, Wang H, Sun L, Chen ZJ. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 2013; 341:1390–4.
55. Aguirre S, Luthra P, Sanchez-Aparicio MT, Maestre AM, Patel J, Lamothe F et al. Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection. Nat Microbiol 2017; 2:17037.
56. Waßermann R, Gulen MF, Sala C, Perin SG, Lou Y, Rybniker J et al. Mycobacterium tuberculosis differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1. Cell Host Microbe 2015; 17:799–810.
57. Collins AC, Cai H, Li T, Franco LH, Li X-D, Nair VR et al. Cyclic GMP-AMP synthase is an innate immune DNA sensor for Mycobacterium tuberculosis. Cell Host Microbe 2015; 17:820–8.
58. Sisquella X, Ofir-Birin Y, Pimentel MA, Cheng L, Abou Karam P, Sampaio NG et al. Malaria parasite DNA-harbouring vesicles activate cytosolic immune sensors. Nat Commun 2017; 8:1985.
59. Hansen K, Prabakaran T, Laustsen A, Jorgensen SE, Rahbaek SH, Jensen SB et al. Listeria monocytogenes induces IFN expression through an IFI16-, cGAS- and STING-dependent pathway. EMBO J 2014; 33:1654–66.
60. Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature 2011; 478:515–8.
61. Dey B, Dey RJ, Cheung LS, Pokkali S, Guo H, Lee J-H et al. A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis. Nat Med 2015; 21:401–6.
62. Marinho FV, Benmerzoug S, Oliveira SC, Ryffel B, Quesniaux VFJ. The emerging roles of STING in bacterial infections. Trends Microbiol 2017; 25:906–18.
63. Archer KA, Durack J, Portnoy DA. STING-dependent type I IFN production inhibits cell-mediated immunity to Listeria monocytogenes. PLoS Pathog 2014; 10:e1003861.
64. Snyder DT, Hedges JF, Jutila MA. Getting “Inside” Type I IFNs: Type I IFNs in intracellular bacterial infections. J Immunol Res 2017; 2017:9361802.
65. Hancks DC, Hartley MK, Hagan C, Clark NL, Elde NC. Overlapping patterns of rapid evolution in the nucleic acid sensors cGAS and OAS1 suggest a common mechanism of pathogen antagonism and escape. PLoS Genet 2015; 11:e1005203.
66. Lemos de Matos A, McFadden G, Esteves PJ. Positive evolutionary selection on the RIG-I-like receptor genes in mammals. PLoS ONE 2013; 8:e81864.
67. Sorci G, Cornet S, Faivre B. Immunity and the emergence of virulent pathogens. Infect Genet Evol 2013; 16:441–6.
68. Gröschel MI, Sayes F, Simeone R, Majlessi L, Brosch R. ESX secretion systems: mycobacterial evolution to counter host immunity. Nat Rev Microbiol 2016; 14:677–91.
69. Uchida L, Espada-Murao LA, Takamatsu Y, Okamoto K, Hayasaka D, Yu F et al. The dengue virus conceals double-stranded RNA in the intracellular membrane to escape from an interferon response. Sci Rep 2014; 4:7395.
70. Neufeldt CJ, Joyce MA, Van Buuren N, Levin A, Kirkegaard K, Gale M et al. The Hepatitis C Virus-induced membranous web and associated nuclear transport machinery limit access of pattern recognition receptors to viral replication sites. PLoS Pathog 2016; 12:e1005428.
71. Jacques DA, McEwan WA, Hilditch L, Price AJ, Towers GJ, James LC. HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis. Nature 2016; 536:349–53.
72. Kindler E, Gil-Cruz C, Spanier J, Li Y, Wilhelm J, Rabouw HH et al. Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication. PLoS Pathog 2017; 13:e1006195.
73. Andrade WA, Firon A, Schmidt T, Hornung V, Fitzgerald KA, Kurt-Jones EA et al. Group B streptococcus degrades cyclic-di-AMP to modulate STING-dependent Type I interferon production. Cell Host Microbe 2016; 20:49–59.
74. Habjan M, Andersson I, Klingström J, Schümann M, Martin A, Zimmermann P et al. Processing of genome 5′ termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 2008; 3:e2032.
75. Decroly E, Canard B. Biochemical principles and inhibitors to interfere with viral capping pathways. Curr Opin Virol 2017; 24:87–96.
76. Schuberth-Wagner C, Ludwig J, Bruder AK, Herzner AM, Zillinger T, Goldeck M et al. A conserved Histidine in the RNA sensor RIG-I controls immune tolerance to N1-2′O-methylated Self RNA. Immunity 2015; 43:41–51.
77. Abdullah Z, Schlee M, Roth S, Mraheil MA, Barchet W, Böttcher J et al. RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids. EMBO J 2012; 31:4153–64.
78. Luecke S, Holleufer A, Christensen MH, Jønsson KL, Boni GA, Sørensen LK et al. cGAS is activated by DNA in a length-dependent manner. EMBO Rep 2017; 18:1707–15.
79. Smith GL, Benfield CTO, Maluquer de Motes C, Mazzon M, Ember SWJ, Ferguson BJ et al. Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol 2013; 94:2367–92.
80. Su C, Zhan G, Zheng C. Evasion of host antiviral innate immunity by HSV-1, an update. Virol J BioMed Central 2016; 13:38.
81. Feng Q, Langereis MA, Lork M, Nguyen M, Hato SV, Lanke K et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol 2014; 88:3369–78.
82. Barral PM, Sarkar D, Fisher PB, Racaniello VR. RIG-I is cleaved during picornavirus infection. Virology 2009; 391:171–6.
83. Papon L, Oteiza A, Imaizumi T, Kato H, Brocchi E, Lawson TG et al. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 2009; 393:311–8.
84. Rodríguez Pulido M, Sánchez-Aparicio MT, Martínez-Salas E, García-Sastre A, Sobrino F, Sáiz M. Innate immune sensor LGP2 is cleaved by the Leader protease of foot-and-mouth disease virus. PLoS Pathog 2018; 14:e1007135.
85. Gori-Savellini G, Valentini M, Cusi MG. Toscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. J Virol 2013; 87:6660–7.
86. Qin L, Ren L, Zhou Z, Lei X, Chen L, Xue Q et al. Rotavirus nonstructural protein 1 antagonizes innate immune response by interacting with retinoic acid inducible gene I. Virol J BioMed Central 2011; 8:526.
87. Zhang H-L, Ye H-Q, Liu S-Q, Deng C-L, Li X-D, Shi P-Y et al. West Nile virus NS1 antagonizes interferon β production by targeting RIG-I and MDA5. J Virol 2017; 91:e02396-16.
88. Lu Y, Qin Z, Wang J, Zheng X, Lu J, Zhang X et al. Epstein–Barr virus miR-BART6-3p inhibits the RIG-I pathway. J Innate Immun 2017; 9:574–86.
89. Hou Z, Zhang J, Han Q, Su C, Qu J, Xu D et al. Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146a. Sci Rep 2016; 6:26150.
90. Zhao J, Zeng Y, Xu S, Chen J, Shen G, Yu C et al. A viral deamidase targets the helicase domain of RIG-I to block RNA-induced activation. Cell Host Microbe 2016; 20:770–84.
91. Kok K-H, Lui P-Y, Ng M-HJ, Siu K-L, Au SWN, Jin D-Y. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 2011; 9:299–309.
92. Kew C, Lui P-Y, Chan C-P, Liu X, Au SWN, Mohr I et al. Suppression of PACT-induced type I interferon production by herpes simplex virus 1 Us11 protein. J Virol 2013; 87:13141–9.
93. Siu K-L, Yeung ML, Kok K-H, Yuen K-S, Kew C, Lui P-Y et al. Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. J Virol 2014; 88:4866–76.
94. Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B et al. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 2013; 14:74–84.
95. Tawaratsumida K, Phan V, Hrincius ER, High AA, Webby R, Redecke V et al. Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor. J Virol 2014; 88:9038–48.
96. Wies E, Wang MK, Maharaj NP, Chen K, Zhou S, Finberg RW et al. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 2013; 38:437–49.
97. Gack MU, Shin YC, Joo C-H, Urano T, Liang C, Sun L et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007; 446:916–20.
98. Oshiumi H, Miyashita M, Inoue N, Okabe M, Matsumoto M, Seya T. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 2010; 8:496–509.
99. Mesman AW, Zijlstra-Willems EM, Kaptein TM, de Swart RL, Davis ME, Ludlow M et al. Measles virus suppresses RIG-I-like receptor activation in dendritic cells via DC-SIGN-mediated inhibition of PP1 phosphatases. Cell Host Microbe 2014; 16:31–42.
100. Rajsbaum R, Albrecht RA, Wang MK, Maharaj NP, Versteeg GA, Nistal-Villán E et al. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog 2012; 8:e1003059.
101. Oshiumi H, Miyashita M, Matsumoto M, Seya T. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog 2013; 9:e1003533.
102. Gupta S, Ylä-Anttila P, Callegari S, Tsai M-H, Delecluse H-J, Masucci MG. Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome. PLoS Pathog 2018; 14:e1006852.
103. Gack MU, Albrecht RA, Urano T, Inn K-S, Huang I-C, Carnero E et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 2009; 5:439–49.
104. Koliopoulos MG, Lethier M, Van der Veen AG, Haubrich K, Hennig J, Kowalinski E et al. Molecular mechanism of influenza A NS1-mediated TRIM25 recognition and inhibition. Nat Commun 2018; 9:1820.
105. Sanchez-Aparicio MT, Feinman LJ, García-Sastre A, Shaw ML. Paramyxovirus V proteins interact with the RIG-I/TRIM25 regulatory complex and inhibit RIG-I signaling. J Virol 2018; 92:396.
106. Chiang C, Pauli E-K, Biryukov J, Feister KF, Meng M, White EA et al. The human Papillomavirus E6 Oncoprotein targets USP15 and TRIM25 to suppress RIG-I-mediated innate immune signaling. J Virol 2018; 92:1.
107. Hu Y, Li W, Gao T, Cui Y, Jin Y, Li P et al. The severe acute respiratory syndrome coronavirus nucleocapsid inhibits Type I interferon production by interfering with TRIM25-mediated RIG-I ubiquitination. J Virol 2017; 91:e02143-16.
108. Manokaran G, Finol E, Wang C, Gunaratne J, Bahl J, Ong EZ et al. Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness. Science 2015; 350:217–21.
109. Lee W, Lee S-H, Kim M, Moon J-S, Kim G-W, Jung H-G et al. Vibrio vulnificus quorum-sensing molecule cyclo(Phe-Pro) inhibits RIG-I-mediated antiviral innate immunity. Nat Commun 2018; 9:1606.
110. Chan YK, Gack MU. A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity. Nat Immunol 2016; 17:523–30.
111. Xing J, Wang S, Lin R, Mossman KL, Zheng C. Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5. J Virol 2012; 86:3528–40.
112. Zhou S, Cerny AM, Zacharia A, Fitzgerald KA, Kurt-Jones EA, Finberg RW. Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J Virol 2010; 84:9452–62.
113. Ling Z, Tran KC, Teng MN. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of β interferon transcription by interacting with RIG-I. J Virol 2009; 83:3734–42.
114. Fan L, Briese T, Lipkin WI. Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J Virol 2010; 84:1785–91.
115. Ren J, Wang Q, Kolli D, Prusak DJ, Tseng C-TK, Chen ZJ et al. Human metapneumovirus M2-2 protein inhibits innate cellular signaling by targeting MAVS. J Virol 2012; 86:13049–61.
116. Ma J, Ketkar H, Geng T, Lo E, Wang L, Xi J et al. Zika virus non-structural protein 4A blocks the RLR-MAVS signaling. Front Microbiol 2018; 9:1350.
117. He Z, Zhu X, Wen W, Yuan J, Hu Y, Chen J et al. Dengue virus subverts host innate immunity by targeting adaptor protein MAVS. J Virol 2016; 90:7219–30.
118. Hwang KY, Choi YB. Modulation of mitochondrial antiviral signaling by human herpesvirus 8 interferon regulatory factor 1. J Virol 2016; 90:506–20.
119. Shi C-S, Qi H-Y, Boularan C, Huang N-N, Abu-Asab M, Shelhamer JH et al. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. J Immunol 2014; 193:3080–9.
120. Wei C, Ni C, Song T, Liu Y, Yang X, Zheng Z et al. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol 2010; 185:1158–68.
121. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005; 437:1167–72.
122. Bender S, Reuter A, Eberle F, Einhorn E, Binder M, Bartenschlager R. Activation of Type I and III interferon response by mitochondrial and peroxisomal MAVS and inhibition by hepatitis C virus. PLoS Pathog 2015; 11:e1005264.
123. Horner SM, Park HS, Gale M. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0. J Virol 2012; 86:3112–20.
124. Lin R, Lacoste J, Nakhaei P, Sun Q, Yang L, Paz S et al. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 2006; 80:6072–83.
125. Choi HJ, Park A, Kang S, Lee E, Lee TA, Ra EA et al. Human cytomegalovirus-encoded US9 targets MAVS and STING signaling to evade type I interferon immune responses. Nat Commun 2018; 9:125.
126. Varga ZT, Grant A, Manicassamy B, Palese P. Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J Virol 2012; 86:8359–66.
127. Yoshizumi T, Ichinohe T, Sasaki O, Otera H, Kawabata S-I, Mihara K et al. Influenza A virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity. Nat Commun 2014; 5:4713.
128. Chatel-Chaix L, Cortese M, Romero-Brey I, Bender S, Neufeldt CJ, Fischl W et al. Dengue virus perturbs mitochondrial morphodynamics to dampen innate immune responses. Cell Host Microbe 2016; 20:342–56.
129. Magalhães AC, Ferreira AR, Gomes S, Vieira M, Gouveia A, Valença I et al. Peroxisomes are platforms for cytomegalovirus' evasion from the cellular immune response. Sci Rep 2016; 6:26028.
130. Zheng C, Su C. Herpes simplex virus 1 infection dampens the immediate early antiviral innate immunity signaling from peroxisomes by tegument protein VP16. Virol J 2017; 14:35.
131. Kamanova J, Sun H, Lara-Tejero M, Galán JE. The Salmonella effector protein SopA modulates innate immune responses by targeting TRIM E3 ligase family members. PLoS Pathog 2016; 12:e1005552.
132. Fiskin E, Bhogaraju S, Herhaus L, Kalayil S, Hahn M, Dikic I. Structural basis for the recognition and degradation of host TRIM proteins by Salmonella effector SopA. Nat Commun 2017; 8:14004.
133. Christensen MH, Jensen SB, Miettinen JJ, Luecke S, Prabakaran T, Reinert LS et al. HSV-1 ICP27 targets the TBK1-activated STING signalsome to inhibit virus-induced type I IFN expression. EMBO J 2016; 35:1385–99.
134. Orzalli MH, Broekema NM, Knipe DM. Relative contributions of Herpes simplex virus 1 ICP0 and VHS to loss of cellular IFI16 vary in different human cell types. J Virol 2016; 90:8351–9.
135. Su C, Zheng C. Herpes simplex virus 1 abrogates the cGAS/STING-mediated cytosolic DNA-sensing pathway via its virion host shutoff protein, UL41. J Virol 2017; 91:e02414–16.
136. Huang J, You H, Su C, Li Y, Chen S, Zheng C. Herpes simplex virus 1 tegument protein VP22 abrogates cGAS/STING-mediated antiviral innate immunity. J Virol 2018; 92:783.
137. Maruzuru Y, Ichinohe T, Sato R, Miyake K, Okano T, Suzuki T et al. Herpes simplex virus 1 VP22 inhibits AIM2-dependent inflammasome activation to enable efficient viral replication. Cell Host Microbe 2018; 23:254–7.
138. Zhang J, Zhao J, Xu S, Li J, He S, Zeng Y et al. Species-specific deamidation of cGAS by Herpes simplex virus UL37 protein facilitates viral replication. Cell Host Microbe 2018; 24:234–5.
139. Diner BA, Lum KK, Toettcher JE, Cristea IM. Viral DNA sensors IFI16 and cyclic GMP-amp synthase possess distinct functions in regulating viral gene expression, immune defenses, and apoptotic responses during Herpesvirus infection. MBio 2016; 7:e01553-16.
140. Huang Z-F, Zou H-M, Liao B-W, Zhang H-Y, Yang Y, Fu Y-Z et al. Human cytomegalovirus protein UL31 inhibits DNA sensing of cGAS to mediate immune evasion. Cell Host Microbe 2018; 24:69–80.e4.
141. Biolatti M, Dell'Oste V, Pautasso S, Gugliesi F, von Einem J, Krapp C et al. Human cytomegalovirus tegument protein pp65 (pUL83) Dampens Type I Interferon production by inactivating the DNA sensor cGAS without affecting STING. J Virol 2018; 92:288.
142. Biolatti M, Dell'Oste V, Pautasso S, von Einem J, Marschall M, Plachter B et al. Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability. J Virol 2016; 90:8238–50.
143. Li T, Chen J, Cristea IM. Human cytomegalovirus tegument protein pUL83 inhibits IFI16-mediated DNA sensing for immune evasion. Cell Host Microbe 2013; 14:591–9.
144. Fu Y-Z, Su S, Gao Y-Q, Wang P-P, Huang Z-F, Hu M-M et al. Human cytomegalovirus tegument protein UL82 inhibits STING-mediated signaling to evade antiviral immunity. Cell Host Microbe 2017; 21:231–43.
145. Kim J-E, Kim Y-E, Stinski MF, Ahn J-H, Song Y-J. Human cytomegalovirus IE2 86 kDa protein induces STING degradation and inhibits cGAMP-mediated IFN-β induction. Front Microbiol 2017; 8:1854.
146. Huang Y, Ma D, Huang H, Lu Y, Liao Y, Liu L et al. Interaction between HCMV pUL83 and human AIM2 disrupts the activation of the AIM2 inflammasome. Virol J 2017; 14:34.
147. Ma Z, Jacobs SR, West JA, Stopford C, Zhang Z, Davis Z et al. Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses. Proc Natl Acad Sci USA 2015; 112:E4306–15.
148. Wu J-J, Li W, Shao Y, Avey D, Fu B, Gillen J et al. Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein. Cell Host Microbe 2015; 18:333–44.
149. Roy A, Dutta D, Iqbal J, Pisano G, Gjyshi O, Ansari MA et al. Nuclear innate immune DNA sensor IFI16 is degraded during lytic reactivation of Kaposi's Sarcoma-associated Herpesvirus (KSHV): role of IFI16 in maintenance of KSHV latency. J Virol 2016; 90:8822–41.
150. Zhang G, Chan B, Samarina N, Abere B, Weidner-Glunde M, Buch A et al. Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS. Proc Natl Acad Sci USA 2016; 113:E1034–43.
151. Lau L, Gray EE, Brunette RL, Stetson DB. DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway. Science 2015; 350:568–71.
152. Georgana I, Sumner RP, Towers GJ, Maluquer de Motes C. Virulent poxviruses inhibit DNA sensing by preventing STING activation. J Virol 2018; 92:e02145–17.
153. Peters NE, Ferguson BJ, Mazzon M, Fahy AS, Krysztofinska E, Arribas-Bosacoma R et al. A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. PLoS Pathog 2013; 9:e1003649.
154. Upton JW, Kaiser WJ, Mocarski ES. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 2012; 11:290–7.
155. Holm CK, Jensen SB, Jakobsen MR, Cheshenko N, Horan KA, Moeller HB et al. Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nat Immunol 2012; 13:737–43.
156. Holm CK, Rahbek SH, Gad HH, Bak RO, Jakobsen MR, Jiang Z et al. Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses. Nat Commun 2016; 7:10680.
157. Ding Q, Gaska JM, Douam F, Wei L, Kim D, Balev M et al. Species-specific disruption of STING-dependent antiviral cellular defenses by the Zika virus NS2B3 protease. Proc Natl Acad Sci USA 2018; 115:E6310–8.
158. Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, Gutman D et al. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog 2012; 8:e1002934.
159. Sun B, Sundström KB, Chew JJ, Bist P, Gan ES, Tan HC et al. Dengue virus activates cGAS through the release of mitochondrial DNA. Sci Rep 2017; 7:3594.
160. Cao Y, Guan K, He X, Wei C, Zheng Z, Zhang Y et al. Yersinia YopJ negatively regulates IRF3-mediated antibacterial response through disruption of STING-mediated cytosolic DNA signaling. Biochim Biophys Acta 2016; 1863:3148–59.
161. Dey RJ, Dey B, Zheng Y, Cheung LS, Zhou J, Sayre D et al. Inhibition of innate immune cytosolic surveillance by an M. tuberculosis phosphodiesterase. Nat Chem Biol 2017; 13:210–7.
162. Movert E, Lienard J, Valfridsson C, Nordström T, Johansson-Lindbom B, Carlsson F. Streptococcal M protein promotes IL-10 production by cGAS-independent activation of the STING signaling pathway. PLoS Pathog 2018; 14:e1006969.